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Abstract In Switzerland, children are prescribed 7.5–
12.5 μg per day of vitamin D3 dissolved in alcohol, but
many families do not adhere to the recommendation. The
aim of the trial was to compare the acceptance of vitamin
D3 dissolved in alcohol or in medium-chain triglycerides
among mothers of Swiss newborn infants. The acceptance
was tested in 42 healthy newborn infants (20 girls and 22
boys) aged between 2 and 7 days. Their neonatal body
weight ranged between 2.225 and 4.150 kg, and the
gestational age between 36 1/7 and 41 3/7 weeks. The
blinded mothers rated the facial reaction of their children by
pointing on a facial hedonic scale. Thirty eight of the 41
mothers, who brought the comparison to completion,
assigned a better score to the oily preparation with no
difference in the remaining three cases (P<0.0001). The
acceptance for the oily preparation was significantly better
both among mothers whose babies were initially presented
the alcoholic preparation and among mothers whose babies
were initially presented the oily preparation. Furthermore,
the acceptance for the oily preparation was better irrespec-
tive of gender of the infant or parity of the mother. In
conclusion, from the perspective of mothers, Swiss new-
born infants prefer the taste of the oily vitamin D3
preparation over the alcoholic preparation.
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Introduction
Vitamin D deficiency rickets is an ancient disease, which
was thought to have been cured in the early twentieth
century [14]. However, despite the availability of vitamin D
and demonstration of its usefulness in preventing rickets,
vitamin D deficiency rickets still exists as a major health
problem with significant morbidity in developing countries
all over the world including Africa and South America, and
has been reported with increasing prevalence in minority
groups in North America and in immigrant populations in
Australia, New Zealand, and Europe [14]. In many
countries, there are reports of a high prevalence of
subclinical vitamin D deficiency in childhood [8].
In addition to rickets and other possible consequences of
disturbed calcium homeostasis, vitamin D deficiency in
infancy and early childhood might increase the incidence of
diabetes mellitus and the risk of tuberculosis, pneumonia,
influenza, and other respiratory tract infections [1, 8, 16].
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Finally, vitamin D deficiency predisposes to further disease
states including multiple sclerosis, systemic lupus eryth-
ematosus, rheumatoid arthritis, and perhaps some forms of
cancer [1, 8].
In the USA, to prevent vitamin D deficiency, it is
currently recommended that all children receive 10.0 μg1
per day of vitamin D from their first days of life through
adolescence [18]. In Switzerland, children receive 7.5 to
12.5 μg of vitamin D3 in an alcoholic solution beginning
during the first month of life [11]. Unfortunately, in
Switzerland, approximately 50% of the families do not
adhere to the recommendation, either because they consider
unsatisfactory the palatability of the alcoholic vitamin D3
preparation or because they oppose “alcoholic drugs” for
socio-cultural reasons [3, 7, 13].
The purpose of the present study with healthy newborn
infants and their mothers was to compare the acceptance of
the standard alcoholic vitamin D3 preparation with that of a
new preparation that contains vitamin D3 dissolved in
medium-chain triglycerides.
Subjects and methods
The single-blind test was performed with 42 Swiss singleton
newborn infants with gestational age of 360/7 weeks or more
and neonatal body weight of 2.000 kg or more and their
mothers. None of them had been previously exposed to a
vitamin D3 preparation. The infants were recruited and tested
immediately before discharge from the well baby nursery,
Ospedale della Beata Vergine, Mendrisio (Switzerland), from
1 March through to 30 April 2010.
Gestational age was assessed from the mother's last
menstrual period, unless the mother's dates were in doubt,
when gestational age was assigned postnatally using the
New Ballard Score [2]. The body weight was considered
appropriate for gestational age in newborn infants with a
birth weight between the 10th and the 90th percentiles
according to the birth weight-for-gestational age charts. An
umbilical cord artery pH of 7.15 or more and a neonatal
Apgar sum score of 7 or more at 1 and 5 min were used to
indicate a newborn infant in good condition.
The study design had been approved by the Institutional
Review Board, and informed consent was obtained from
the mothers of the infants. Acceptance was determined by
the single administration of two liquid cholecalciferol
formulations commercialized by Wild AG, Basel, Switzer-
land: (a) one drop of the standard preparation Vi-De3®
(“alcoholic vitamin D3”), which contains vitamin D3
dissolved in 65% ethanol (113 μg/mL, corresponding to
2.5 μg per drop) and (b) one drop of Vitamin D3 Wild®
(“oily vitamin D3”), which is available since 2009 and
contains vitamin D3 dissolved in medium-chain triglycer-
ides (500 μg/mL, corresponding to 12.5 μg per drop). After
the mother gave informed consent, the interviewer took the
enrolled newborn baby and the mother to the test area. Each
study consisted of a session lasting approximately 5–
10 min. The acceptance was determined by a single-blind
taste test of one drop of both the alcoholic and the oily
vitamin D3 formulations. Immediately thereafter, the
blinded mother was asked to rate the hedonic facial reaction
of the infant by pointing on a scale that depicts 4 degrees
of pleasure: 4=“good,” 3=“not sure,” 2=“bad,” 1=“really
bad” [6, 9]. Between the tasting of the two formulations,
the baby received some milk to rinse its mouth (the
time between the tasting of the two formulations was at
least 3 min).
An independent statistician had generated a randomiza-
tion list to balance the order of presentation of the
preparations so that each preparation was tasted first an
equal number of times and prepared 42 sequentially
numbered, opaque sealed envelopes containing the assign-
ment. The envelopes were opened in sequence after
accompanying the infant with the mother to the test area.
Since a sample size of 20 is considered appropriate for
this type of study [6], we performed ad abundantiam the
test in 42 newborns and their mothers. The scores from the
hedonic scales were analyzed using the Wilcoxon matched
paired signed rank test. Significance was assumed when
P<0.05 (two tailed).
Results
The 42 Caucasian mothers recruited for the comparison had
born 20 girls and 22 boys with a neonatal body weight
ranging between 2.225 and 4.150 kg and a gestational age
ranging between 361/7 and 413/7 weeks (Table 1). Eighty-
three percent of the infants had been delivered vaginally,
and the neonatal body weight was appropriate for gesta-
tional age in 88% of them. The umbilical cord artery pH
and the neonatal Apgar sum score failed to detect perinatal
or neonatal alarm indicators in 98% and 88% of them,
respectively.
The 42 children were between 2 and 7 days of age
when the acceptance test was performed. The secundi-
parous mother of a vaginally born, breastfed boy with a
neonatal body weight of 2.845 kg and a gestational age
of 375/7 weeks initially offered the alcoholic vitamin D3
preparation was not able to rate the facial reaction of her
baby. Thirty eight of the 41 mothers, who brought the
comparison to completion, assigned a better facial score to
the oily vitamin D3 preparation, with no difference
1 Multiply the number of micrograms by 40 to convert micrograms to
international units.
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between the two preparations in the remaining three cases.
From the perspective of the mothers, none of the infants
preferred the alcoholic preparation. The difference be-
tween the two preparations was highly significant (P<
0.0001, Fig. 1). Moreover, the mothers never evaluated the
alcoholic vitamin D3 preparation as “good” or “not sure.”
The test preference was similar among 20 mothers
whose babies were initially presented the alcoholic vitamin
D3 preparation (better score for oily vitamin D3, N=18; no
difference, N=2; P<0.0002) and among 21 mothers whose
babies were initially presented the oily vitamin D3
preparation (better score for oily vitamin D3, N=20; no
difference, N=1; P<0.0001). Furthermore, the acceptance
for the oily vitamin D3 preparation was significantly higher
both among mothers of 21 boys (better score for oily
vitamin D3, N=20; no difference, N=1; P<0.0001) and
among mothers of 20 girls (better score for oily vitamin D3,
N=18; no difference, N=2; P<0.0002). Finally, the
acceptance for the oily vitamin D3 preparation was
significantly better both among 14 nulliparous (better score
for oily vitamin D3, N=13; no difference, N=1; P<0.0002)
and among 27 non-nulliparous (better score for oily vitamin
D3, N=25; no difference, N=2; P<0.0001) mothers.
Discussion
The present study tested the acceptance of two liquid
preparations that contain vitamin D3 dissolved either in
alcohol or in medium-chain triglycerides among mothers of
healthy newborn infants. The results demonstrate that the
acceptance for the oily vitamin D3 preparation is signifi-
cantly superior to that of the alcoholic preparation.
In this trial, the acceptance of the two vitamin D3
formulations among mothers of newborn infants was assessed
with 2.5 μg of alcoholic and 12.5 μg of oily vitamin D3. The
use of identical doses, obviously a situation closer to reality,
might have further advantaged the oily preparation.
Facial hedonic scales have achieved a large popularity to
determine the degree of liking for foods and beverages [4,
5, 12]. Three- to 5-point facial hedonic scales like those
used in the present trial have been widely used to evaluate
the acceptance for drug suspensions and for crushed drugs
with children 4 years or more of age [6]. The scales were
also used to assess the taste of liquid drugs in newborns and
small infants [6, 9]. Like in other trials performed with
children 3 years or less of age, in the present study, infant
facial reactions following drug administration were inter-
preted by the parents to score acceptance [6, 9].
The major limitation of the study resides in the fact that
facial hedonic scales, albeit frequently used and very
popular, still are unvalidated tools for assessing acceptance
of drug formulation or measuring pain among newborn
infants [6, 17].
The clear-cut preference for oily vitamin D3 observed in the
present trial might be related to the burning sensation in the
throat that is caused by 65% ethanol [9]. This has generated
the impression that alcohol has a strong taste [3]. The poor
palatability of alcoholic vitamin D3 is not associated with
some toxic potential. As a matter of fact, the daily dose of this
preparation contains an insignificant amount of ethanol.
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Fig. 1 Acceptance of alcoholic vitamin D3 and oily vitamin D3
among mothers of 41 Caucasian newborn infants (20 girls and 21
boys), who brought the trial to completion. The difference between the
two preparations was highly significant (P<0.0001). The reaction of
the child was rated using a facial hedonic scale depicting the following
degrees of pleasure: 4=“good,” 3=“not sure,” 2=“bad,” 1=“really
bad.” The figure indicates among others that 27 mothers graded oily
vitamin D3 as “really bad” and 10 graded oily vitamin D3 as “good”
Table 1 Characteristics of 42 Caucasian newborn infants recruited for
the present study
Variable
Gender, ♀/♂ 20:22
Age, days 4 (3–5)
Mother nulliparous, N 14 (33%)
Vaginal delivery, N 35 (83%)
Gestational age
Duration, weeks 390/7 (376/7–395/7)
Duration, 371/7 weeks or more, N 38 (90%)
Neonatal body weight
Absolute value, kg 3.125 (2.850–3.470)
Appropriate for gestational age, N 37 (88%)
Umbilical cord artery pH ≥7.15, N 41 (98%)
Apgar score ≥7 at 1 and 5 min, N 37 (88%)
Breastfeeding, N 38 (90%)
The results are given either as median with interquartile range, which
includes half of the data points, or as relative frequency with percentage
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Nonetheless, unfounded concerns related to the alcohol
content of vitamin D preparations are not rare [3].
Most Swiss infants are currently prescribed either
10.0 μg per day of vitamin D3, i.e., four drops of the
standard alcoholic preparation, or 12.5 μg per day, i.e., one
drop of the new oily preparation. In some cases, switching
from the standard alcoholic to the new alcoholic prepara-
tion resulted in an excessive intake of 50.0 μg per day of
vitamin D3 [15].
The results of the present report are supported by those
of a study which indicates that in newborn infants the
acceptance for vitamin D3 dissolved in peanut oil is
superior to that of vitamin D3 dissolved in ethanol [9].
Since the prevalence of peanut allergy is increasing in
recent years, some authorities currently recommend not to
introduce peanuts for the first 6 months of life [10]. This
advice is based on the findings of studies which suggest
that exposure to peanuts in early life may increase the risk
of peanut allergy [10].
Conclusion
Appreciating the preference for drug preparations in
childhood is of great value [6]. This small trial indicates
that from the perspective of mothers of Swiss newborn
infants, the taste of oily vitamin D3 is significantly better
than that of alcoholic vitamin D3.
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